Stay updated on Pembrolizumab-Epacadostat Combo in Bladder Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab-Epacadostat Combo in Bladder Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab-Epacadostat Combo in Bladder Cancer Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The page no longer displays the 403 error and its study-record breadcrumbs or the NIH transition notice. The updated view shows the site header and footer, with no main-page content visible.
    Difference
    2%
    Check dated 2026-11-10T20:52:59.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The site revision identifier changed from v3.7.2 to v3.8.0 while the study page continued to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-03T21:29:06.000Z thumbnail image
  3. Check
    27 days ago
    Change Detected
    Summary
    A notice about NIH website terminology appears above the ClinicalTrials.gov page, which still displays a 403 error instead of the study record. The site revision identifier changes from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-20T21:57:02.000Z thumbnail image
  4. Check
    41 days ago
    Change Detected
    Summary
    The footer revision changes from v3.7.0 to v3.7.1; the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-06T21:48:02.000Z thumbnail image
  5. Check
    55 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error, replacing the previously visible study record content and navigation. This indicates an access restriction is in effect for this study page.
    Difference
    18%
    Check dated 2026-09-22T22:56:31.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    The page's revision tag has been updated to v3.7.0, replacing the previous v3.6.6. This signals that the study record has been refreshed to a newer version.
    Difference
    0.1%
    Check dated 2026-09-15T21:35:08.000Z thumbnail image

Stay in the know with updates to Pembrolizumab-Epacadostat Combo in Bladder Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab-Epacadostat Combo in Bladder Cancer Clinical Trial page.